New and Emerging Therapies in the Management of Bladder Cancer

por Osterman, Chelsea K., Milowsky, Matthew I.
Publicado 2020

Bladder preservation in muscle-invasive bladder cancer: a comprehensive review

por Hamad, Judy, McCloskey, Hannah, Milowsky, Matthew I., Royce, Trevor, Smith, Angela
Publicado 2020

Carcinomatous meningitis in a patient with Her2/neu expressing bladder cancer following trastuzumab and chemotherapy: a case report and review of the literature

por Goodman, Oscar B, Milowsky, Matthew I, Kaplan, Jodi, Hussain, Maha, Nanus, David M
Publicado 2009

Secondary Immune Thrombocytopenia in Metastatic Renal Cell Carcinoma: A Case Report and Discussion of the Literature

por Cockrell, Dillon C., Kasthuri, Raj S., Altun, Ersan, Rose, Tracy L., Milowsky, Matthew I.
Publicado 2020

Trends in Initial Systemic Therapy for Elderly Patients with Metastatic Clear Cell Renal Cell Carcinoma

por Osterman, Chelsea K., Deal, Allison M., Milowsky, Matthew I., Bjurlin, Marc A., Rose, Tracy L.
Publicado 2020

Metachronous Bilateral Testicular Leydig-Like Tumors Leading to the Diagnosis of Congenital Adrenal Hyperplasia (Adrenogenital Syndrome)

por Vukina, Josip, Chism, David D., Sharpless, Julie L., Raynor, Mathew C., Milowsky, Matthew I., Funkhouser, William K.
Publicado 2015

Phase I Study of Everolimus in Combination with Gemcitabine and Split-Dose Cisplatin in Advanced Urothelial Carcinoma

por Abida, Wassim, Milowsky, Matthew I., Ostrovnaya, Irina, Gerst, Scott R., Rosenberg, Jonathan E., Voss, Martin H., Apolo, Andrea B., Regazzi, Ashley M., McCoy, Asia S., Boyd, Mariel E., Bajorin, Dean F.
Publicado 2016

Associations between Tumor Vascularity, Vascular Endothelial Growth Factor Expression and PET/MRI Radiomic Signatures in Primary Clear-Cell–Renal-Cell-Carcinoma: Proof-of-Concept S...

por Yin, Qingbo, Hung, Sheng-Che, Wang, Li, Lin, Weili, Fielding, Julia R., Rathmell, W. Kimryn, Khandani, Amir H., Woods, Michael E., Milowsky, Matthew I., Brooks, Samira A., Wallen, Eric. M., Shen, Dinggang
Publicado 2017

Phase II trial of palbociclib in patients with metastatic urothelial cancer after failure of first-line chemotherapy

por Rose, Tracy L., Chism, David D., Alva, Ajjai S., Deal, Allison M., Maygarden, Susan J., Whang, Young E., Kardos, Jordan, Drier, Anthony, Basch, Ethan, Godley, Paul A., Dunn, Mary W., Kim, William Y., Milowsky, Matthew I.
Publicado 2018

A real-world evaluation of radium-223 in combination with abiraterone or enzalutamide for the treatment of metastatic castration-resistant prostate cancer

por Kim, Stephanie I., Szeto, Andy H., Morgan, Katherine P., Brower, Blaine, Dunn, Mary W., Khandani, Amir H., Godley, Paul A., Rose, Tracy L., Basch, Ethan M., Milowsky, Matthew I., Whang, Young E., Crona, Daniel J.
Publicado 2021

Correction: A real-world evaluation of radium-223 in combination with abiraterone or enzalutamide for the treatment of metastatic castration-resistant prostate cancer

por Kim, Stephanie I., Szeto, Andy H., Morgan, Katherine P., Brower, Blaine, Dunn, Mary W., Khandani, Amir H., Godley, Paul A., Rose, Tracy L., Basch, Ethan M., Milowsky, Matthew I., Whang, Young E, Crona, Daniel J
Publicado 2021

BODY COMPOSITION, PHYSICAL FUNCTION AND QUALITY OF LIFE IN HEALTHY MEN AND ACROSS DIFFERENT STAGES OF PROSTATE CANCER

por Hanson, Erik D., Stopforth, Cameron K., Alzer, Mohamdod, Carver, Jackson, Lucas, Alexander R., Whang, Young E., Milowsky, Matthew I., Bartlett, David B., Harrison, Michael R., Hayes, Alan, Bitting, Rhonda L., Deal, Allison M., Hackney, Anthony C., Battaglini, Claudio L.
Publicado 2021

Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma

por Kamat, Ashish M., Bellmunt, Joaquim, Galsky, Matthew D., Konety, Badrinath R., Lamm, Donald L., Langham, David, Lee, Cheryl T., Milowsky, Matthew I., O’Donnell, Michael A., O’Donnell, Peter H., Petrylak, Daniel P., Sharma, Padmanee, Skinner, Eila C., Sonpavde, Guru, Taylor, John A., Abraham, Prasanth, Rosenberg, Jonathan E.
Publicado 2017

Erratum to: Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma

por Kamat, Ashish M., Bellmunt, Joaquim, Galsky, Matthew D., Konety, Badrinath R., Lamm, Donald L., Langham, David, Lee, Cheryl T., Milowsky, Matthew I., O’Donnell, Michael A., O’Donnell, Peter H., Petrylak, Daniel P., Sharma, Padmanee, Skinner, Eila C., Sonpavde, Guru, Taylor, John A., Abraham, Prasanth, Rosenberg, Jonathan E.
Publicado 2017

Collaborative study from the Bladder Cancer Advocacy Network for the genomic analysis of metastatic urothelial cancer

por Damrauer, Jeffrey S., Beckabir, Wolfgang, Klomp, Jeff, Zhou, Mi, Plimack, Elizabeth R., Galsky, Matthew D., Grivas, Petros, Hahn, Noah M., O’Donnell, Peter H., Iyer, Gopa, Quinn, David I., Vincent, Benjamin G., Quale, Diane Zipursky, Wobker, Sara E., Hoadley, Katherine A., Kim, William Y., Milowsky, Matthew I.
Publicado 2022

Correction to: Fibroblast growth factor receptor 3 alterations and response to immune checkpoint inhibition in metastatic urothelial cancer: a real world experience

por Rose, Tracy L., Weir, William H., Mayhew, Gregory M., Shibata, Yoichiro, Eulitt, Patrick, Uronis, Joshua M., Zhou, Mi, Nielsen, Matthew, Smith, Angela B., Woods, Michael, Hayward, Michele C., Salazar, Ashley H., Milowsky, Matthew I., Wobker, Sara E., McGinty, Katrina, Millburn, Michael V., Eisner, Joel R., Kim, William Y.
Publicado 2022

Mocetinostat for patients with previously treated, locally advanced/metastatic urothelial carcinoma and inactivating alterations of acetyltransferase genes

por Grivas, Petros, Mortazavi, Amir, Picus, Joel, Hahn, Noah M., Milowsky, Matthew I., Hart, Lowell L., Alva, Ajjai, Bellmunt, Joaquim, Pal, Sumanta K., Bambury, Richard M., O’Donnell, Peter H., Gupta, Sumati, Guancial, Elizabeth A., Sonpavde, Guru P., Faltaos, Demiana, Potvin, Diane, Christensen, James G., Chao, Richard C., Rosenberg, Jonathan E.
Publicado 2018

Patterns of Bladder Preservation Therapy Utilization for Muscle-Invasive Bladder Cancer

por Rose, Tracy L., Deal, Allison M., Ladoire, Sylvain, Créhange, Gilles, Galsky, Matthew D., Rosenberg, Jonathan E., Bellmunt, Joaquim, Wimalasingham, Akhila, Wong, Yu-Ning, Harshman, Lauren C., Chowdhury, Simon, Niegisch, Guenter, Liontos, Michalis, Yu, Evan Y., Pal, Sumanta K., Chen, Ronald C., Wang, Andrew Z., Nielsen, Matthew E., Smith, Angela B., Milowsky, Matthew I.
Publicado 2016

A randomized phase 2 trial of pembrolizumab versus pembrolizumab and acalabrutinib in patients with platinum‐resistant metastatic urothelial cancer

por Zhang, Tian, Harrison, Michael R., O'Donnell, Peter H., Alva, Ajjai S., Hahn, Noah M., Appleman, Leonard J., Cetnar, Jeremy, Burke, John M., Fleming, Mark T., Milowsky, Matthew I., Mortazavi, Amir, Shore, Neal, Sonpavde, Guru P., Schmidt, Emmett V., Bitman, Bojena, Munugalavadla, Veerendra, Izumi, Raquel, Patel, Priti, Staats, Janet, Chan, Cliburn, Weinhold, Kent J., George, Daniel J.
Publicado 2020

Discrete microfluidics for the isolation of circulating tumor cell subpopulations targeting fibroblast activation protein alpha and epithelial cell adhesion molecule

por Witek, Małgorzata A., Aufforth, Rachel D., Wang, Hong, Kamande, Joyce W., Jackson, Joshua M., Pullagurla, Swathi R., Hupert, Mateusz L., Usary, Jerry, Wysham, Weiya Z., Hilliard, Dawud, Montgomery, Stephanie, Bae-Jump, Victoria, Carey, Lisa A., Gehrig, Paola A., Milowsky, Matthew I., Perou, Charles M., Soper, John T., Whang, Young E., Yeh, Jen Jen, Martin, George, Soper, Steven A.
Publicado 2017